a hrefhttps:www.fiercepharma.commanufacturinglilly-resilience-plot-750m-outlay-increase-production-injectables-ohio hreflangenLilly, Resilience commit 750M to boost US diabetes, obesity med productiona

Eli Lilly has doubled down on its partnership with CDMO Resilience as the companies plan to invest 750 million to increase production of Lillys KwikPen injectable device for its diabetes and obesity medicines Mounjaro and Zepbound.